<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>opioid &#8211; UF Innovate</title>
	<atom:link href="https://innovate.research.ufl.edu/tag/opioid/feed/" rel="self" type="application/rss+xml" />
	<link>https://innovate.research.ufl.edu</link>
	<description>Building business on innovation</description>
	<lastBuildDate>Mon, 13 Oct 2025 19:11:46 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png</url>
	<title>opioid &#8211; UF Innovate</title>
	<link>https://innovate.research.ufl.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>AI-Powered Clinical Tool Aims To Prevent Opioid Disorder Relapse (UF Pharmacy)</title>
		<link>https://innovate.research.ufl.edu/ai-powered-clinical-tool-aims-to-prevent-opioid-disorder-relapse/</link>
		
		<dc:creator><![CDATA[sooyoungryu]]></dc:creator>
		<pubDate>Mon, 13 Oct 2025 19:09:59 +0000</pubDate>
				<category><![CDATA[News Brief]]></category>
		<category><![CDATA[AI-powered clinical support tool]]></category>
		<category><![CDATA[artificial intelligence]]></category>
		<category><![CDATA[Mahmudul Hasan]]></category>
		<category><![CDATA[National Institute on Drug Abuse]]></category>
		<category><![CDATA[National Institutes of Health]]></category>
		<category><![CDATA[opioid]]></category>
		<category><![CDATA[Opioid Disorder]]></category>
		<category><![CDATA[PROTECT tool]]></category>
		<category><![CDATA[University of Pittsburgh]]></category>
		<guid isPermaLink="false">https://innovate.research.ufl.edu/?p=20295</guid>

					<description><![CDATA[UF researchers led the development of PROTECT, an AI-powered clinical tool that uses machine learning to predict relapse risk in patients undergoing buprenorphine treatment for opioid use disorder, supported by a National Institutes of Health grant.]]></description>
										<content:encoded><![CDATA[<p>An AI-powered clinical support tool will help prevent relapse in patients receiving buprenorphine treatment for opioid use disorder — a condition that affects hundreds of thousands of people in America every year.</p>
<p>The PROTECT tool, devised by researchers at the University of Florida and the University of Pittsburgh with a $3.6 million grant from the National Institutes of Health and the National Institute on Drug Abuse, uses machine learning algorithms to identify buprenorphine patients who are at high risk of relapsing and provides recommendations for next steps.</p>
<p>&nbsp;</p>
<p>Read more about <a href="https://pharmacy.ufl.edu/2025/10/09/ai-powered-clinical-tool-aims-to-prevent-opioid-disorder-relapse/">AI-Powered Clinical Tool Aims To Prevent Opioid Disorder Relapse.</a></p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>UF Scripps Study: Opioid Drug Tolerance Develops From Interplay of Key Gene and Cholesterol</title>
		<link>https://innovate.research.ufl.edu/uf-scripps-opioid-tolerance-gene/</link>
		
		<dc:creator><![CDATA[Sara Dagen]]></dc:creator>
		<pubDate>Tue, 23 Aug 2022 00:00:00 +0000</pubDate>
				<category><![CDATA[News Brief]]></category>
		<category><![CDATA[Scripps Research]]></category>
		<category><![CDATA[biomedical research]]></category>
		<category><![CDATA[opioid]]></category>
		<category><![CDATA[UF Health]]></category>
		<category><![CDATA[UF Scripps]]></category>
		<guid isPermaLink="false">https://scaddev1.com/uf-scripps-opioid-tolerance-gene/</guid>

					<description><![CDATA[UF Scripps Biomedical Research scientists have discovered a key gene that is shedding light on how people develop tolerance to pain-relievers over time, a problem that raises risk of addiction and overdose.]]></description>
										<content:encoded><![CDATA[
<p><a href="https://scripps.ufl.edu/">UF Scripps Biomedical Research</a> scientists have discovered a key gene that is shedding light on how people develop tolerance to pain-relievers over time, a problem that raises risk of addiction and overdose.</p>



<p><a></a>The finding could open the door to a new generation of pain medications designed to function differently, and lower the chance patients could grow dependent on opioids and other drugs like morphine and fentanyl.</p>



<p>People who suffer severe pain from stroke, trauma or cancer know that over time, the most effective prescription pain relievers lose power, said UF Scripps neuroscientist <a href="https://scripps.ufl.edu/profile/martemyanov-kirill/" target="_blank" rel="noreferrer noopener">Kirill Martemyanov, Ph.D</a>. To provide patients with the same pain-relieving effect, doctors often must prescribe higher and higher doses.</p>



Learn more about <a href="https://ufhealth.org/news/2022/uf-scripps-study-opioid-drug-tolerance-develops-interplay-key-gene-and-cholesterol">UF Scripps Study: Opioid Drug Tolerance Develops From Interplay of Key Gene and Cholesterol<a />
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>AI Tool Will Predict Patients at High Risk for Opioid Use Disorder and Overdose</title>
		<link>https://innovate.research.ufl.edu/ai-tool-will-predict-patients-at-high-risk-for-opioid-use-disorder-and-overdose/</link>
		
		<dc:creator><![CDATA[Sara Dagen]]></dc:creator>
		<pubDate>Fri, 12 Nov 2021 00:00:00 +0000</pubDate>
				<category><![CDATA[News Brief]]></category>
		<category><![CDATA[UF Inventors]]></category>
		<category><![CDATA[opioid]]></category>
		<guid isPermaLink="false">https://scaddev1.com/ai-tool-will-predict-patients-at-high-risk-for-opioid-use-disorder-and-overdose/</guid>

					<description><![CDATA[University of Florida researchers are developing a new artificial intelligence tool that will help clinicians identify patients at high risk for opioid use disorder and overdose.]]></description>
										<content:encoded><![CDATA[
<p>University of Florida researchers are developing a new artificial intelligence tool that will help clinicians identify patients at high risk for opioid use disorder and overdose.</p>



<p>The tool will use data from patients’ electronic medical records to guide clinicians in safely and effectively prescribing opioid medications. The project is supported by a five-year, $3.2 million grant from the National Institute on Drug Abuse, or NIDA, and aims to reduce the unprecedented rise in opioid overdose and opioid use disorder in the United States.</p>



Read more about <a href="http://www.healthnewsdigest.com/news/Patient_230/AI-Tool-Will-Predict-Patients-at-High-Risk-for-Opioid-Use-Disorder-and-Overdose.shtml">AI Tool Will Predict Patients at High Risk for Opioid Use Disorder and Overdose.</a>



<p></p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
